Compare AU

Compare CURE vs. JPEQ

Compare shares and ETFs on the ASX that you can trade on Pearler.

Global X S&P Biotech ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Global X S&P Biotech ETF (CURE) and the Jpm Us100Q Eq Prem Inc Active ETF (Managed Fund) (JPEQ). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

CURE

JPEQ

Popularity

Low

Low

Pearlers invested

80

3

Median incremental investment

$620.00

$2,000.00

Median investment frequency

Monthly

Fortnightly

Median total investment

$1,298.77

$9,971.20

Average age group

> 35

> 35


Key Summary

CURE

JPEQ

Strategy

CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

JPEQ.AX was created on 2023-05-23 by JPMorgan. The fund's investment portfolio concentrates primarily on total market equity. The investment objective of the Fund is to seek current income while maintaining prospects for capital appreciation.

Top 3 holdings

AbbVie Inc (2.62 %)

Alnylam Pharmaceuticals Inc (2.59 %)

Amgen Inc (2.59 %)

JPMorgan Nasdaq Equity Premium Inc ETF (98.96 %)

Top 3 industries

Health Care (100.00 %)

Other (10.24 %)

Top 3 countries

United States (97.17 %)

Switzerland (1.51 %)

United Kingdom of Great Britain and Northern Ireland (1.16 %)

United States (97.22 %)

Netherlands (1.57 %)

Brazil (0.79 %)

Management fee

0.45 %

0.4 %


Key Summary

CURE

JPEQ

Issuer

Global X

JPMorgan

Tracking index

S&P Biotechnology Select Industry

Asset class

ETF

ETF

Management fee

0.45 %

0.4 %

Price

$49.01

$65.60

Size

$34.191 million

N/A

10Y return

N/A

N/A

Annual distribution yield (5Y)

4.24 %

2.81 %

Market

ASX

ASX

First listed date

12/11/2018

24/05/2023

Purchase fee

$6.50

$6.50


Community Stats

CURE

JPEQ

Popularity

Low

Low

Pearlers invested

80

3

Median incremental investment

$620.00

$2,000.00

Median investment frequency

Monthly

Fortnightly

Median total investment

$1,298.77

$9,971.20

Average age group

> 35

> 35


Pros and Cons

CURE

JPEQ

Pros

  • Higher distribution yield

  • Higher exposure to US market

  • Lower management fee

  • Higher price growth

Cons

  • Lower exposure to US market

  • Higher management fee

  • Lower price growth

  • Lower distribution yield

CURE

JPEQ

Lower exposure to US market

Higher exposure to US market

Higher management fee

Lower management fee

Lower price growth

Higher price growth

Higher distribution yield

Lower distribution yield

Home